Endovascular Repair of Bilateral Internal Mammary Artery Aneurysms in a Patient with Marfan Syndrome—A Case Report

Abstract

Marfan syndrome (MFS) is an autosomal dominant condition that is caused by abnormal synthesis of connective tissue. The syndrome classically affects the ocular, musculoskeletal, and cardiovascular systems. The most common cardiovascular manifestations include mitral valve prolapse/regurgitation and aortic aneurysms at high risk of rupture and dissection. However, internal mammary artery (IMA) true aneurysms are rarely reported. In this case report, we describe a 43-year-old male patient with MFS and three previous thoracotomies referred for endovascular repair of bilateral IMA true aneurysms. To the best of our knowledge, there are no cases of endovascular treatment of bilateral IMA true aneurysms reported in the literature.

Keywords

Marfan syndrome - internal mammary artery aneurysm - wall graft stent - covered stent

• References

• 1 Hilhorst-Hofstee Y, Rijlaarsdam ME, Scholte AJ , et al. The clinical spectrum of missense mutations of the first aspartic acid of cbEGF-like domains in fibrillin-1 including a recessive family. Hum Mutat 2010; 31 (12) E1915-E1927
• 2 Ramirez F, Godfrey M, Lee B , et al. Marfan syndrome and related disorders. In: Scriver CR, Beaudet AL, Sly WS, , et al, eds. The Metabolic and Molecular Basis of Inherited Disease, 7th ed. New York, NY: McGraw Hill; 1995: 4079
• 3 Judge DP, Dietz HC. Marfan's syndrome. Lancet 2005; 366 (9501) 1965-1976
• 4 Sakai LY, Keene DR, Glanville RW, Bächinger HP. Purification and partial characterization of fibrillin, a cysteine-rich structural component of connective tissue microfibrils. J Biol Chem 1991; 266 (22) 14763-14770
• 5 Akhurst RJ. TGF beta signaling in health and disease. Nat Genet 2004; 36 (8) 790-792
• 6 Mizuguchi T, Collod-Beroud G, Akiyama T , et al. Heterozygous TGFBR2 mutations in Marfan syndrome. Nat Genet 2004; 36 (8) 855-860
• 7 Dietz HC, Ramirez F, Sakai LY. Marfan's syndrome and other microfibrillar diseases. Adv Hum Genet 1994; 22: 153-186
• 8 Bunton TE, Biery NJ, Myers L, Gayraud B, Ramirez F, Dietz HC. Phenotypic alteration of vascular smooth muscle cells precedes elastolysis in a mouse model of Marfan syndrome. Circ Res 2001; 88 (1) 37-43
• 9 Cohen PR, Schneiderman P. Clinical manifestations of the Marfan syndrome. Int J Dermatol 1989; 28 (5) 291-299
• 10 Adams JN, Trent RJ. Aortic complications of Marfan's syndrome. Lancet 1998; 352 (9142) 1722-1723
• 11 Prockop DJ, Czarny-Ratajczak M. Heritable disorders of the connective tissue. In: Fauci AS, Kasper DL, Longo DL, , et al, ed. Harrison's Principles of the Internal Medicine. 17th ed. New York, NY: McGraw-Hill; 2008: 2461-2469
• 12 Loeys BL, Dietz HC, Braverman AC , et al. The revised Ghent nosology for the Marfan syndrome. J Med Genet 2010; 47 (7) 476-485
• 13 Phan TG, Sakulsaengprapha A, Wilson M, Wing R. Ruptured internal mammary artery aneurysm presenting as massive spontaneous haemothorax in a patient with Ehlers-Danlos syndrome. Aust N Z J Med 1998; 28 (2) 210-211
• 14 Ishiwata S, Nishiyama S, Nakanishi S , et al. Coronary artery disease and internal mammary artery aneurysms in a young woman: possible sequelae of Kawasaki disease. Am Heart J 1990; 120 (1) 213-217
• 15 Giles JA, Sechtin AG, Waybill MM, Moser Jr RP. Bilateral internal mammary artery aneurysms: a previously unreported cause for an anterior mediastinal mass. AJR Am J Roentgenol 1990; 154 (6) 1189-1190
• 16 Common AA, Pressacco J, Wilson JK. Internal mammary artery aneurysm in Marfan syndrome: case report. Can Assoc Radiol J 1999; 50 (1) 47-50
• 17 Rose JF, Lucas LC, Bui TD, Mills Sr JL. Endovascular treatment of ruptured axillary and large internal mammary artery aneurysms in a patient with Marfan syndrome. J Vasc Surg 2011; 53 (2) 478-482
• 18 Kim SJ, Kim CW, Kim S , et al. Endovascular treatment of a ruptured internal thoracic artery pseudoaneurysm presenting as a massive hemothorax in a patient with type I neurofibromatosis. Cardiovasc Intervent Radiol 2005; 28 (6) 818-821